by Sam Eskandari | Feb 19, 2020 | News
VANCOUVER, British Columbia, February 19, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announces that it has entered into a debt settlement agreement with its Interim CEO and CFO, Mr. Peter...
by Sam Eskandari | Feb 13, 2020 | News
VANCOUVER, British Columbia, February 13, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the...
